Table 2.
The mean of survival rates for ALL, AML, and all patients
| Variables | ALL | P value | AML | P value | |
|---|---|---|---|---|---|
| Age groups | 1-4 yrs 5-9 yrs 10-14 yrs |
51.4 46.5 48.7 |
0.2 | 37 48.6 54.3 |
0.09 |
| Sex | Male Female |
49.7 49.9 |
0.8 | 46.4 47.6 |
0.9 |
| Residency | Shiraz city Fars except Shiraz Other province |
46.9 51.9 46.6 |
0.4 | 43.9 52.4 46.5 |
0.4 |
| Initial white blood cell | Leukopenia Normal Leukocytosis |
49.1 55.8 40.3 |
0.4 | 46.8 51.5 47.3 |
0.8 |
| Initial Hemoglobin | Abnormal Normal |
47.5 56.4 |
0.2 | 45.6 57 |
0.1 |
| Initial Platelet | Thrombocytopenia Normal Thrombocytosis |
44.7 59.8 34.7 |
0.004 | 48.3 45.7 - |
0.9 |
| Relapse | Yes No |
37.9 58.6 |
<0.001 | 37.1 54.2 |
0.002 |
| Number of relapses | 0 1 ≥ 2 |
58.6 44.7 28.2 |
<0.001 | 54.2 46.3 30.5 |
<0.001 |
| Immuno-phenotype | Pre B-Cell Common AML T-Cell |
40.8 54.1 - 45.1 |
0.19 | - - - - |
|
ALL: Acute lymphoblastic leukemia; AML: Acute myeloblastic leukemia